Tiberiu Pana

Medicine & Life Sciences

1. Stroke 100%
2. Mortality 63%
3. Cohort Studies 51%
4. Meta-Analysis 45%
5. Inpatients 32%
6. Systematic Reviews 28%
7. Population 26%
8. Chemokine CCL2 25%
9. Hospital Mortality 22%
10. Cerebral Hemorrhage 22%
11. Myocardial Infarction 21%
12. Cardiovascular Diseases 20%
13. Heart Failure 19%
14. Aged, 80 and over 18%
15. Sex Characteristics 17%
16. Atrial Fibrillation 16%
17. Pandemics 15%
18. Recurrence 14%
19. Biomarkers 13%
20. Prospective Studies 12%
21. Thrombectomy 11%
22. Neoplasms 11%
23. Nutritional Status 11%
24. Odds Ratio 10%
25. Thailand 10%
26. Hospitalization 10%
27. Hypertension 9%
28. Nomograms 9%
29. Atrial Heart Septal Defects 8%
30. Coronary Disease 8%
31. Diabetes Mellitus 8%
32. Glomerular Filtration Rate 8%
33. Anthracyclines 8%
34. Chemotactic Factors 8%
35. Cholinergic Antagonists 8%
36. Public Policy 8%
37. Left Ventricular Dysfunction 7%
38. Confidence Intervals 7%
39. Health Policy 7%
40. Ethics 7%
41. Diabetes Complications 7%
42. Blood Pressure 7%
43. Chronic Renal Insufficiency 7%
44. Pulmonary Hypertension 7%
45. Comorbidity 7%
46. Systemic Lupus Erythematosus 7%
47. Shock 6%
48. Patient Readmission 6%
49. Logistic Models 6%
50. Body Mass Index 6%